Posted on 11/26/19
Columbia Care Continues Florida Expansion with Four Dispensary Openings
NEW YORK--(BUSINESS WIRE)--Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP), one of the largest fully integrated operators in the global medical cannabis industry with licenses . . .
Posted on 11/26/19
BiondVax Announces Third Quarter 2019 Financial Results and Business Update
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced its . . .
Posted on 11/26/19
A 45% Premium: Here's Why The Medicines Company Is Worth More to Novartis Than It Was to You
Novartis (NYSE:NVS) is buying The Medicines Company (NASDAQ:MDCO) for $85 per share. That's a 45% premium above the closing price prior to the acquisition rumor being . . .
Posted on 11/25/19
Ferring and Blackstone Life Sciences Invest Over $570M In Novel Gene Therapy
Ferring Pharmaceuticals and Blackstone Life Sciences today announced the joint investment of over $570 million USD in nadofaragene firadenovec
Posted on 11/25/19
Better Buy: Johnson & Johnson vs. Eli Lilly
Longtime leaders, short-term laggards. That's a quick rundown of how Johnson & Johnson (NYSE:JNJ) and Eli Lilly (NYSE:LLY) stocks have performed. While both big pharma stocks . . .
Posted on 11/25/19
Watch Out, Pfizer: This $2 Billion Biotech Is Coming for You
Pfizer (NYSE:PFE) is out to an early lead with Vyndaqel, a drug that treats cardiomyopathy caused by transthyretin (TTR)-mediated amyloidosis (ATTR-CM), in which the TTR protein . . .
Posted on 11/25/19
Why I'm Holding On to My Bristol-Myers Squibb Shares Now That the Celgene Acquisition Has Closed
Goodbye, Celgene. Hello, Bristol-Myers Squibb (NYSE:BMY).With Bristol-Myers Squibb's acquisition of Celgene closing on Wednesday, one of my favorite biotech stocks is now gone. Celgene became a . . .
Posted on 11/25/19
TytoHome Named One of TIME's Best Inventions of 2019
Tyto Care, creator of the healthcare industry's first all-in-one modular device and telehealth platform for on-demand, remote medical exams, today announced that TytoHome has been named . . .
Posted on 11/22/19
Better Buy: Eli Lilly vs. Pfizer
Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) have been two of the best-performing big pharma stocks over the past decade. Nonetheless, these two pharma titans have both . . .
Posted on 11/22/19
CURE Media Group Expands Its Strategic Alliance Partnership Program With the Skin Cancer Foundation
CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, which reaches over 1 million patients, survivors and caregivers across an industry-leading multimedia platform devoted solely to cancer updates and research, . . .
Posted on 11/21/19
FAIR Health Wins Six eHealthcare Leadership Awards for 2019
FAIR Health has won six eHealthcare Leadership Awards for 2019, as announced on November 6 at the Healthcare Internet Conference, sponsored by Greystone.Net, in Orlando, Florida. . . .
Posted on 11/21/19
Celgene: Bargain Bin At Bristol-Myers Squibb Deal Closing
SummaryBristol-Myers expects to close the Celgene acquisition on November 20.The merger is immediately 40% accretive to BMY earnings placing 2020 estimates far above $6 per share.The . . .
Posted on 11/20/19
Tonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering
NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), clinical-stage biopharmaceutical company, announced today the closing of . . .
Posted on 11/19/19
NanoVibronix Provides Business Update for the Third Quarter of 2019
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today provided a business update . . .
Posted on 11/18/19
Plainview Health Corp Receives 2019 Best of West Long Branch Award
Plainview Health Corp has been selected for the 2019 Best of West Long Branch Award in the Vitamin & Supplement Store category.Each year, the Award Program . . .
Posted on 11/18/19
Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, today announced . . .
Posted on 11/18/19
FDA Approves Pfizer’s Biosimilar, ABRILADA (adalimumab-afzb) for Multiple Inflammatory Conditions
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved ABRILADA(adalimumab-afzb), as a biosimilar to Humira® (adalimumab),1 . . .
Posted on 11/18/19
Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) , an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed . . .
Posted on 11/18/19
Tonix Pharmaceuticals Prices $9.0M Public Offering
NEW YORK, Nov. 15, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today the pricing of an underwritten public . . .
Posted on 11/18/19
Prestige Consumer Healthcare Announces Offering of $400 Million Senior Notes
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) announced today that its wholly-owned subsidiary, Prestige Brands, Inc., intends to offer, subject . . .
Posted on 11/18/19
Taro Announces Commencement of Tender Offer to Repurchase up to $225 Million
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it has commenced a modified “Dutch auction” tender offer to repurchase up to $225 million . . .
Posted on 11/18/19
Cedar Crest’s Continuing Care Neighborhood Named Best Nursing Home by U.S. News & World Report
The continuing care neighborhood of Cedar Crest, a senior living community developed and managed by Erickson Living, has been awarded a Best Nursing Home designation by . . .
Posted on 11/14/19
AzurRx BioPharma Announces Equity Purchase Agreement for up to $15M with Lincoln Park Capital Fund
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today . . .
Posted on 11/14/19
NeurologyLive Adds Jefferson Headache Center to Its Strategic Alliance Partnership Program
CRANBURY, N.J.--(BUSINESS WIRE)--NeurologyLive,a multimedia platform dedicated to providing health care professionals treating neurological diseases with direct access to expert-driven, practice-changing news and insights in neurology, welcomes . . .
Posted on 11/14/19
Editas Expands Its Celgene Partnership After Another Strong Quarter
Editas Medicine (NASDAQ:EDIT) released third-quarter 2019 results on Tuesday morning. At first glance, its revenue and earnings numbers appeared to detail a terrible quarter, notably with . . .
New York
